PREPARATIVE AND ANALYTICAL SEPARATION OF THE ZOPICLONE ENANTIOMERS AND DETERMINATION OF THEIR AFFINITY TO THE BENZODIAZEPINE RECEPTOR-BINDING SITE

被引:47
作者
BLASCHKE, G [1 ]
HEMPEL, G [1 ]
MULLER, WE [1 ]
机构
[1] CENT INST MENTAL HLTH,DEPT PSYCHOPHARMACOL,MANNHEIM,GERMANY
关键词
ZOPICLONE; CHIRAL LIQUID CHROMATOGRAPHY; ENANTIOSEPARATION; FRACTIONAL CRYSTALLIZATION; CYCLOPYRROLONE; BENZODIAZEPINE RECEPTOR BINDING;
D O I
10.1002/chir.530050605
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the preparative separation of rac-zopiclone using malic acid as the resolving agent. Furthermore, two different methods for the analytical determination of zopiclone enantiomers by HPLC on chiral stationary phases are described. The benzodiazepine receptor binding of the isolated enantiomers was investigated. Half-maximal inhibitory concentrations of (+)- and (-)-zopiclone were 21 or 1, 130 nmol/liter, respectively, indicating a more than 50 times higher affinity of the (+)-enantiomer toward the receptor. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:419 / 421
页数:3
相关论文
共 9 条
[1]   BRAIN RECEPTORS AND ZOPICLONE [J].
BLANCHARD, JC ;
BOIREAU, A ;
JULOU, L .
PHARMACOLOGY, 1983, 27 :59-69
[2]   STRUCTURE OF SURICLONE, A BENZODIAZEPINE RECEPTOR AGONIST [J].
CODDING, PW ;
SZKARADZINSKA, MB ;
DUKE, NE .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1988, 44 :1938-1942
[3]   DETERMINATION OF ZOPICLONE ENANTIOMERS IN PLASMA BY LIQUID-CHROMATOGRAPHY USING A CHIRAL CELLULOSE CARBAMATE COLUMN [J].
FERNANDEZ, C ;
BAUNE, B ;
GIMENEZ, F ;
THUILLIER, A ;
FARINOTTI, R .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 572 (1-2) :195-202
[4]   ZOPICLONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY AS AN HYPNOTIC [J].
GOA, KL ;
HEEL, RC .
DRUGS, 1986, 32 (01) :48-65
[5]  
Haefely W. E., 1985, ADV DRUG RES, V14, P165
[6]  
JACQMIN P, 1986, ARCH INT PHARMACOD T, V282, P26
[7]  
MOHLE H, 1991, 2ND INT S CHIR DISCR, P167
[8]  
TRIFILETTI RR, 1984, MOL PHARMACOL, V26, P470
[9]  
TRIFILETTI RR, 1984, MOL PHARMACOL, V26, P458